Syquant Capital SAS is based out of Paris. Their last reported 13F filing for Q4 2023 included $22,157,000 in managed 13F securities
and a top 10 holdings concentration of 100.0%. Syquant Capital SAS's largest holding is Mirati Therapeutics Inc with shares held of 153,920. Whalewisdom has at least 21 13F filings
2023-12-31
Top Buys (13F)
Name | % Change |
---|---|
MRTX Mirati Therapeutics | 40.81% |
LAZ Lazard Inc. | 32.48% |
ICVX Icosavax Inc | 13.56% |
KRTX Karuna Therapeutics | 11.61% |
LOGI Logitech Internation | 0.58% |
2023-12-31
Top Sells (13F)
Name | % Change |
---|---|
HZNP Horizon Therapeutics | 63.55% |
ATVI Activision Blizzard | 28.06% |
TWNK Hostess Brands Inc C | 2.39% |
CPRI Capri Holdings Ltd ( | 2.35% |
NATI National Instruments | 1.25% |
2023-12-31
13F Holdings Summary
Name | $ Change |
---|---|
MRTX Mirati Therapeutics | 40.81% |
LAZ Lazard Inc. | 32.48% |
ICVX Icosavax Inc | 13.56% |
KRTX Karuna Therapeutics | 11.61% |
LOGI Logitech Internation | 0.58% |
2023-12-31
13F Activity
Market Value | $22.2m, Prior: $255m |
New Purchases | 7 stocks |
Added To | 0 stocks |
Sold out of | 9 stocks |
Reduced holdings in | 0 stocks |
Top 10 Holdings % | 100% |
Turnover %[1] | 228.57% |
Turnover Alt %[2] | 100% |
Time Held Top 20 | 0 quarters |
Time Held Top 10 | 0 quarters |
Time Held All | 0.29 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2023-12-31
13F Sector Allocation Over Time
2023-12-31
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31